Race to stop second strokes: major trial tests common drug combo
NCT ID NCT06360120
Summary
This study aims to see if adding one of two cholesterol-lowering drugs (atorvastatin or rosuvastatin) to the blood thinner clopidogrel is better at preventing a second stroke in people who just had their first major ischemic stroke. It will enroll 600 adults and compare which drug combination leads to fewer new strokes and better recovery over 3 months. The goal is to find the most effective routine to control stroke risk and improve outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kafr Elsheikh University Hospital
RECRUITINGKafr ash Shaykh, 33511, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.